A MIL series metal‒organic framework (MOF), MIL-100(Fe), was successfully synthesized at the nanoscale and fully characterized by TEM, TGA, XRD, FTIR, DLS, and BET. A toxicological assessment was performed using two different cell lines: human normal liver cells (HL-7702) and hepatocellular carcinoma (HepG2). In vitro cytotoxicity of MIL-100(Fe) was evaluated by the MTT assay, LDH releasing rate assay, DAPI staining, and annexin V/PI double staining assay. The safe dose of MIL-100(Fe) was 80 μg/mL. It exhibited good biocompatibility, low cytotoxicity, and high cell survival rate (HL-7702 cells' viability >85.97%, HepG2 cells' viability >91.20%). Therefore, MIL-100(Fe) has a potential application as a drug carrier.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480057PMC
http://dx.doi.org/10.3390/molecules24071211DOI Listing

Publication Analysis

Top Keywords

metal‒organic framework
8
cells' viability
8
vitro toxicity
4
toxicity study
4
study porous
4
porous ironiii
4
ironiii metal‒organic
4
framework mil
4
mil series
4
series metal‒organic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!